CannTrust secures supply agreements in all Atlantic Provinces
VAUGHAN, ON, Sept. 13, 2018 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company",TSX: TRST), one of Canada's leading licensed producers and most trusted brands of medical cannabis is also emerging as a leader within the adult-use recreational cannabis market. Today, CannTrust announced supply agreements with Nova Scotia, New Brunswick, Prince Edward Island and Newfoundland. CannTrust has now achieved national distribution for its three recreational brands – liiv, Synr.g and Xscape – and has a long-term strategy to be a market share leader in the Canadian recreational space.
"We are pleased that all of the Atlantic provinces selected CannTrust as a trusted retail partner. Our portfolio strategy has been well received with provincial boards and has resulted in listings across all brands. The momentum will only grow as we begin to share our quality products with Canadians across the country in October," says Brad Rogers, President, CannTrust.
Beginning October 17, Canadians from coast-to-coast will have access to CannTrust's quality, standardized cannabis products grown in the company's Niagara, Ontario perpetual harvest facility, which is setting new industry standards for product excellence and cost effectiveness. CannTrust's recreational brands will be available in a broad range of formats including dried flower, pre-rolled joints, oil and capsules.
CannTrust is investing in future innovation with significant investments and advances in nanotechnology that will enable the Company to produce cannabis-infused beverages that are neutral in taste, and clear as water. This proprietary technology will further accelerate CannTrust's dominance in this emerging area within Canadian and global markets.
This week, CannTrust announced plans for an exclusive partnership with Breakthru Beverage Group – the largest Canadian beverage alcohol broker of premium spirits, wine and beer brands. Breakthru will establish a cannabis-focused sales brokerage company to represent CannTrust's specialty products to Canadian adult consumers.
Since its inception in 2014, CannTrust has led the Canadian market in producing a standardized product.
As a federally regulated licensed producer, CannTrust brings more than 40 years of pharmacy and healthcare experience to the medical cannabis industry. CannTrust currently operates the recently completed 250,000 sq. ft. Phase One redevelopment of its 450,000 sq. ft. Niagara Perpetual Harvest Facility. The 200,000 sq. ft. Phase Two redevelopment is expected to be operational in the third quarter and the projected 600,000 sq. ft. greenhouse expansion has begun and is fully funded. The industry's broadest product portfolio is prepared and packaged at the 60,000 sq. ft. manufacturing centre of excellence in Vaughan, Ontario.
CannTrust is committed to research and innovation, as well as contributing to the growing body of evidence-based research regarding the use and efficacy of cannabis. Our product development teams along with our exclusive global pharma partner, Apotex Inc., are diligently innovating and developing products that will make it easier for patients to use medical cannabis. We support ongoing patient education about medical cannabis and have a compassionate use program to support patients with financial needs.
For more information, please visit: www.CannTrust.ca.